None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female adult subjects in general good health as determined from a recent medical history. 2.Subjects in the age group of 30-55 years (both ages inclusive). 3.Subjects having periorbital Melanosis/ under eye dark- circle on grade 2 or more as per MSCR photo numerical scale (Refer Appendix-2) 4.Subject having eye puffiness in under eye area on grade 2 or more as per MSCR photo numerical scale (Refer Appendix-2) 5.Subject should be willing to abstain from other under eye treatment during the study period. 6.Subjects willing to give a voluntary written informed consent and agree to come for regular follow up. 7.Subject agreeable for photography. 8.Subjects willing to abide by and comply with the study protocol. 9.Subjects who have not participated in a similar investigation in the past two weeks. 10.Subjects who are willing not to participate in any other clinical study during participation in the current study
Exclusion criteria
Exclusion criteria: 1.A known history or present condition of allergic response to any cosmetic products. 2.Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study. 3.Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy. 4.Subjects having eye infection or allergy as per medical history. 5.Subjects having extremely sensitive eye condition. 6.Subjects having eye disorders like cataract, conjunctivitis, etc. as per medical history 7.Subjects who are pregnant, lactating or nursing. 8.Intense sun exposure/ photo allergen city/toxicity. 9.Chronic illness which may influence the cutaneous state. 10.Subject participating in any other cosmetic or therapeutic trial. 11.Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Visible reduction in appearance of Dark Circles 2. Visible reduction in appearance of fine lines & wrinkles / Crowâ??s feet wrinkles 3. Reduces Puffiness eyes 4. Imparts moisturization 5. Reduces droopy/saggy eyesTimepoint: Day 0, Day 28, Day 42 and Day 56 | — |
Secondary
| Measure | Time frame |
|---|---|
| The product safety profile by dermatologist and ophthalmologistTimepoint: Day 0, Day 28, Day 42 and Day 56 | — |
Countries
India
Contacts
Transformative Learning Solution Pvt. Ltd.